Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SFDA Speeds Up Release Of Vaccines To Quake-Hit Regions

This article was originally published in PharmAsia News

Executive Summary

Due to the urgent needs of earthquake victims, China's State FDA has, for the second time, adjusted the procedure for release of blood products and vaccines to speed up the distribution of relief supplies. SFDA and vaccine manufacturers will synchronize the quality inspection and approval of badly needed vaccine and blood products that have been produced but are awaiting approval, as well as products still being churned out. These include tetanus immunoglobulin, human albumin, cholera toxin B subunit vaccine, hepatitis A vaccine, Japanese B encephalitis vaccine, diphtheria and tetanus combined vaccine, tetanus vaccine and hemorrhagic fever vaccine. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts